Cerebral small vessel disease: new treatment possibilities for the little-known condition affecting millions of people

<p>Cerebral small vessel disease (CSVD), which notably increases the risk of stroke and cognitive disorders, is estimated to affect more than 5 million people in France alone. In the absence of a curative treatment, the prevention of cardiovascular risk factors remains the most effective strategy today. However, promising new therapeutic avenues are being explored.</p> <p>Cerebral small vessel disease is a chronic condition that affects the smallest arteries of the brain, those that continuously supply the deep regions essential for memory, attention, and coordination.</p> <p>Over time, these vessels become stiffer, thicken, or become more fragile and permeable. The consequences of this situation are far from insignificant, since cerebral small vessel disease promotes strokes, cognitive disorders, walking difficulties, as well as loss of independence.</p> <p>In France, cerebral small vessel disease is estimated to affect more than 5 million people aged 65 and over. To date, no treat